Duopharma Biotech Berhad Declares Interim Dividend for the 30 June 2023, Payable on 22 September 2023

Duopharma Biotech Berhad is a Malaysia-based pharmaceutical company. The Company is engaged in the manufacturing and distribution of pharmaceutical products. Its business segments include Consumer Healthcare (CHC), Ethical Classic Business (ECB) and Ethical Specialty Business (ESB). The CHC is engaged in the manufacturing, marketing and distribution of over-the-counter products, such as vitamins and supplements, analgesics, eyecare and antacids to the domestic, regional and international markets. Its CHC brands include Flavettes, CHAMPS, Uphamol and Eye Glo. The ECB comprises more than 300 generic drugs manufactured by the Company, such as Crystorvas, Prelica and Omesec, among others. The ESB is focused on drugs for targeted conditions, as well as medical devices and consumables. It has also diversified into the biosimilars space with technology and commercialization collaborations with international partners. ERYSAA, Basalog One and Zuhera are a few commercialized biosimilar brands.